Healthcare Sales & Marketing Network News: MM-003

Searching News Database: MM-003

HSMN NewsFeed - 31 May 2013
Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Jan 2007
Pharmion Submits European Marketing Authorization Application for Thalidomide Pharmion(R) for Untreated Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Jun 2006
THALOMID(R) (Thalidomide) Delays Time to Disease Progression in Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jan 2006
Pharmion Provides EU Registration Strategy Update for Thalidomide
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 9 Jan 2006
THALOMID(R) Pivotal Phase III Multiple Myeloma Trial Reaches Pre-Specified Interim Endpoint
Biopharmaceuticals

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.